SCIENTIFIC BOARDS TO REVIEW FDA DECISIONS

被引：0
|
作者：
不详
机构：
来源：
QUALITY PROGRESS | 1979年 / 12卷 / 10期
关键词：
D O I：
暂无
中图分类号：
T [工业技术];
学科分类号：
08 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] FDA decisions on new oncological drugs
    Li, Guanqiao
    Liu, Yang
    He, Ruyi
    Su, Ling
    Chen, Xiaoyuan
    LANCET ONCOLOGY, 2022, 23 (05): : 583 - 586
  • [22] Research excellence and scientific advisory boards
    Goeser, Maya
    Wimmer, Stefan
    Sauer, Johannes
    SCIENCE AND PUBLIC POLICY, 2023, 50 (06) : 1044 - 1058
  • [23] Regulatory dependence and Scientific Advisory Boards
    Chok, Jay Inghwee
    RESEARCH POLICY, 2009, 38 (05) : 710 - 725
  • [24] Financing decisions as a source of conflict in venture boards
    Forbes, Daniel P.
    Korsgaard, M. Audrey
    Sapienza, Harry J.
    JOURNAL OF BUSINESS VENTURING, 2010, 25 (06) : 579 - 592
  • [25] FDA and EMEA pool scientific advice
    Alla Katsnelson
    Nature Biotechnology, 2004, 22 : 1490 - 1491
  • [26] Funding decisions, peer review, and scientific excellence in physical sciences, chemistry, and geosciences
    van Leeuwen, Thed N.
    Moed, Henk F.
    RESEARCH EVALUATION, 2012, 21 (03) : 189 - 198
  • [27] FDA and EMEA pool scientific advice
    Katsnelson, A
    NATURE BIOTECHNOLOGY, 2004, 22 (12) : 1490 - 1491
  • [28] FDA Decisions and Public Deliberation:Challenges and Opportunities
    Gusmano, Michael K.
    PUBLIC ADMINISTRATION REVIEW, 2013, 73 : S115 - S126
  • [29] FDA post-marketing safety decisions
    Klein, Donald F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1305 - 1306
  • [30] Recent FDA decisions: Impact on the future of obesity
    Antal, Ildiko
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 : S179 - S180
12345